News in brief: Foetal exposures to ASMs; A possible drug to prevent CTE; Evaluating the blood-labyrinth barrier in health and illness

Reassurance on neurodevelopmental risks from antiseizure medications Cognitive outcomes in children at 2 years of age do not appear to be impacted by exposure to anti seizure medications (ASMs) during pregnancy. A multicentre US study, published in JAMA Neurology, compared 292 children of women with epilepsy taking ASMs such as lamotrigine and/or levetiracetam, and 90 ...

Already a member?

Login to keep reading.

© 2022 the limbic